Welcome to this week’s Oddsmaker Top 25 Best and Worst. First, a brief update on the recently weekly performance of the Oddsmaker Top 25 Best and Worst Picks:

#1 IMPP – Imperial Petroleum Inc. | OM Score 147.1 | Near Pass, 3/5 signature, Super Multiple 141.5 (highest in the universe), OM2 87.3, Trifecta Ratio 0.73. Imperial Petroleum is a Greece-based shipping company that owns product and crude tankers plus dry-bulk carriers. The market prices it at a deep discount: net cash is ~96% of its $256M market cap, so the business is valued near zero. Shares sit 16% above their 200-day average, and sell-side targets imply ~59% upside. Bull: RAVG 99.5, CAS 95.4, ROIC 17% and a cash-rich balance sheet. Bear: the 0.07x EV/EBITDA comes mostly from cash, and its Super Multiple has swung from 250 to 25 to 141 in three weeks. Biggest upside factor: cash nearly equal to its market cap (CAS 95.4). Risks to the long: (1) history of dilutive share issuance; (2) related-party transactions with the controlling shareholder; (3) volatile tanker rates.

#2 HCI – HCI Group, Inc. | OM Score 127.3 | Near Pass, 4/5 signature, Super Multiple 103.5, OM2 82.7, Trifecta Ratio 0.97. HCI writes homeowners insurance, mainly in Florida, through HomeOwners Choice and TypTap, and owns insurance software through Exzeo. The market rewards its post-reform profitability: shares sit 12% above their 200-day average, with sell-side targets ~29% higher. Bull: EQS 95.2 (best in the book), ROIC 28%, net cash ~34% of market cap and CAS 86.4. Bear: one major hurricane can wipe out a year of earnings, and forward EBITDA is filled from trailing data (TTM flag). Biggest upside factor: earnings quality and capital strength (EQS 95.2, CAS 86.4). Risks to the long: (1) catastrophe losses from a landfalling Florida hurricane; (2) higher reinsurance costs at the next renewal; (3) Florida regulatory or litigation changes that reverse the recent reforms.

#3 VFF – Village Farms International, Inc. | OM Score 128.3 | Near Pass, 2/5 signature, Super Multiple 98.4, OM2 78.5, Trifecta Ratio 0.60. Village Farms grows greenhouse produce and runs Pure Sunfarms, one of Canada’s largest cannabis producers, plus medical cannabis exports from the Netherlands. The market treats it as a cheap cannabis option: a $2.84 stock with sell-side targets implying ~105% upside, trading 12% above its 200-day average. Bull: FRM 70.3, CAS 77.0, TRS 81.2 and fast-growing EBITDA. Bear: ROIC is only 6.5%, EQS is 47.7, and it matches just 2 of 5 top-1% traits. Biggest upside factor: margin expansion in cannabis (FRM 70.3). Risks to the long: (1) wholesale cannabis prices keep falling in Canada; (2) delays in US federal cannabis reform; (3) penny-stock volatility (beta 1.14).

#4 DEC – Diversified Energy Company | OM Score 130.4 | Near Pass, 2/5 signature, Super Multiple 104.8, OM2 75.9, Trifecta Ratio 0.67. Diversified buys and runs mature natural gas wells, mostly in Appalachia, and is growing through acquisitions. The market discounts it for debt and well-cleanup liabilities: shares are 7% below their 200-day average and fell 9% over 10 days, while sell-side targets imply ~55% upside. Bull: FRM 91.7 (best in the book), RAVG 94.1, a 9.8% forward FCF yield and ~60% forward revenue growth. Bear: net debt is ~3.0x market cap, CAS is only 37.9, and EQS is 44.6. Biggest upside factor: strong forward cash generation and rising estimates (FRM 91.7, RAVG 94.1). Risks to the long: (1) leverage if gas prices fall; (2) costs to plug old wells (asset-retirement obligations); (3) the cost of integrating acquisitions.

#5 CMCL – Caledonia Mining Corporation Plc | OM Score 136.4 | Near Pass, 4/5 signature, Super Multiple 115.9 (2nd highest in the book), OM2 75.6, Trifecta Ratio 0.96. Caledonia runs the Blanket gold mine in Zimbabwe and is developing the larger Bilboes project. The market applies a heavy Zimbabwe discount: 2.8x forward EV/EBITDA, with sell-side targets implying ~87% upside. Shares fell 7% over 10 days. Bull: CAS 85.1, EQS 74.8, ROIC 12% and net cash ~12% of market cap. Bear: RAVG 1.9, meaning estimates are being cut, and Bilboes spending drives a -20% forward FCF yield. Biggest upside factor: a cheap multiple on a profitable mine (2.8x EV/EBITDA, Trifecta Ratio 0.96). Risks to the long: (1) Zimbabwe currency, royalty and political risk; (2) a falling gold price (beta 2.0); (3) Bilboes cost overruns or dilutive financing.

#6 ELA – Envela Corporation | OM Score 125.2 | Near Pass, 4/5 signature, Super Multiple 60.0, OM2 73.4, Trifecta Ratio 0.87. Envela runs DGSE jewelry and bullion stores in Texas and ECHG, which refurbishes and resells used electronics for businesses. The market has sold it off: shares are 36% below their 200-day average (TRS 2.1) and fell 11% over 10 days, but sell-side targets imply ~101% upside. Bull: CAS 90.7, EQS 81.5, ROIC 26% and ~48% forward revenue growth. Bear: 14.2x forward EV/EBITDA is the richest in the book, and its Super Multiple is the weakest. Biggest upside factor: strong capital returns (CAS 90.7, ROIC 26%). Risks to the long: (1) momentum keeps falling (TRS 2.1); (2) swings in gold and silver prices hit bullion volumes; (3) a small, illiquid stock ($324M market cap, OLI 46.3).

#7 TREE – LendingTree, Inc. | OM Score 139.3 | Near Pass, 4/5 signature, Super Multiple 113.6, OM2 67.9, Trifecta Ratio 0.92. LendingTree runs an online marketplace that matches consumers with lenders and insurers for mortgages, loans, credit cards and insurance. The market has given up on it: shares are 33% below their 200-day average (TRS 2.5), and sell-side targets imply ~121% upside. Bull: OM Score 139.3 (2nd highest in the book), ROIC 25%, an 11.7% forward FCF yield and only 0.5x forward EV/Sales. Bear: net debt is ~0.9x market cap, and lead-generation revenue swings with rates and insurer ad budgets. Biggest upside factor: cash generation at a distressed multiple (FCF/EV 11.7%). Risks to the long: (1) insurers cut marketing spend; (2) high rates keep mortgage volume weak; (3) AI search tools take traffic from comparison sites (beta 1.84).

#8 INR – Infinity Natural Resources, Inc. | OM Score 128.5 | Near Pass, 2/5 signature, Super Multiple 104.3, OM2 67.8, Trifecta Ratio 0.71. Infinity is a young oil and gas producer in Appalachia (Utica and Marcellus) that went public in 2025. The market is skeptical: shares fell 16% over 10 days and sit 15% below their 200-day average, while sell-side targets imply ~77% upside. Bull: RAVG 93.9, ~75% forward revenue growth and a 3.6x forward EV/EBITDA. Bear: net debt is ~2.2x market cap, forward FCF is negative (-2.6% yield), and CAS (31.7) and EQS (34.6) are the weakest in the book. Biggest upside factor: rising estimates on fast production growth (RAVG 93.9). Risks to the long: (1) leverage while spending ahead of cash flow; (2) weaker oil and gas prices; (3) 17.5% short interest on a $237M market cap.

#9 ATNI – ATN International, Inc. | OM Score 131.0 | Near Pass, 3/5 signature, Super Multiple 100.3, OM2 66.9, Trifecta Ratio 0.81. ATN provides telecom and broadband in rural US markets and in international markets including Guyana, Bermuda and the US Virgin Islands. The market prices it as a no-growth utility: sell-side targets imply ~140% upside (largest in the book), and shares are 5% above their 200-day average. Bull: EQS 62.7, TRS 66.1, a 5.6x forward EV/EBITDA and a 3.3% forward FCF yield with government-funded broadband builds. Bear: forward revenue growth of just 2%, FRM 38.1, OLI 11.0 with net insider selling, and net debt ~0.8x market cap. Biggest upside factor: a steep discount to sell-side value. Risks to the long: (1) competition and regulation in Guyana; (2) cuts to federal subsidy programs; (3) leverage limits capital returns.

#10 VRRM – Verra Mobility Corporation | OM Score 130.0 | Near Pass, 1/5 signature (weakest in the book), Super Multiple 102.9, OM2 64.3, Trifecta Ratio 0.44. Verra runs toll and violation processing for rental-car fleets, red-light and speed cameras for cities, and parking software. Shares collapsed ~70% in May after Avis ended its contract (effective September 2026), and the CEO left. The stock is 60% below its 200-day average (TRS 0.2). Bull: a 9.5% forward FCF yield, 14.7% forward FCF margin, a 5.0x forward EV/EBITDA and sell-side targets ~101% above the price. Bear: net debt is ~1.9x market cap, ROIC is only 3.3%, and CAS is 33.1. Biggest upside factor: cash flow at a distressed multiple (FCF/EV 9.5%). Risks to the long: (1) other rental-car customers leave; (2) refinancing risk with high leverage; (3) shareholder litigation and the transition to a new CEO.

#1 SPCE – Virgin Galactic Holdings, Inc. | OM Score -138.1 | Near Pass, 5/5 signature, Super Multiple -210.6, OM2 94.6, Trifecta Ratio 0.00. Virgin Galactic is building its Delta-class spaceships for suborbital space tourism and has paused flights until they are ready. The market still prices in a launch-driven revival: a $465M market cap and 8.1x forward EV/Sales on almost no revenue, at a price 33% above the OM target. Bear: EQS 1.9, FRM 0.7, ROIC -35% and a -51% forward FCF yield. Bull: a cash runway that funds the Delta program, and sell-side targets still ~16% above the price. Biggest downside factor: cash burn with no revenue (FCF/EV -0.51). Risks to the short: (1) VSR 98.5 (highest in the book), beta 3.8 and 23.8% short interest; (2) Delta test-flight milestones can spark squeezes; (3) equity raises often follow rallies, not declines.

#2 SDGR – Schrödinger, Inc. | OM Score -210.1 | Near Pass, 4/5 signature, Super Multiple -279.4, OM2 93.7, Trifecta Ratio 0.03. Schrödinger sells physics-based drug-discovery software and develops its own drug pipeline. Shares rose 51% over 10 days in an AI drug-discovery sector rally, sit 92% above their 200-day average and trade 35% above sell-side targets. Bear: BDR 99.9 (highest in the book), EQS 12.6, negative EBITDA and ROIC -12%. Bull: net cash ~14% of market cap, a growing software business, and recent target raises from BMO, TD Cowen and KeyBanc. Biggest downside factor: a price far ahead of fundamentals (BDR 99.9). Risks to the short: (1) Q3 results on 11-4; (2) positive pipeline data or pharma partnership milestones; (3) AI drug-discovery momentum (beta 2.1, 14.8% short interest).

#3 AI – C3.ai, Inc. | OM Score -159.5 | Near Pass, 3/5 signature, Super Multiple -218.6, OM2 93.5, Trifecta Ratio 0.16. C3.ai sells enterprise AI application software to industrial, energy and government customers. The market has lost faith after leadership turnover and falling sales, yet the stock still trades 18% above sell-side targets and 41% above the OM target. Bear: forward revenue expected to fall 38%, FRM 1.7, ROIC -55% and a -12% forward FCF yield. Bull: net cash ~35% of market cap, federal and defense contracts, and a brand tied to the AI theme. Biggest downside factor: shrinking revenue (FRM 1.7). Risks to the short: (1) 29% short interest and beta 2.2 (VSR 94.6); (2) a takeover bid for a cash-rich, beaten-down software name; (3) a large contract win that resets the growth story.

#4 PI – Impinj, Inc. | OM Score -48.5 | Composite, 2/5 signature, Super Multiple -215.3, OM2 93.4, Trifecta Ratio 0.55. Impinj makes RAIN RFID chips and readers used to tag and track retail, logistics and supply-chain items. The market prices it as a growth leader: 57.8x forward EV/EBITDA and 13.2x forward EV/Sales, with shares 32% above their 200-day average and sitting right at sell-side targets. Bear: MCR 91.6, BDR 95.5 and ROIC -5.5%. Bull: EBITDA is positive, EQS is 55.8, and RFID adoption in apparel and food is growing. Biggest downside factor: a rich multiple on a cyclical chip business (MCR 91.6). Risks to the short: (1) beta 3.0 and 9% short interest; (2) Score of -48.5 is just above the -50 strict line, so the signal is borderline; (3) big retailer mandates (e.g. food-tagging rollouts) can lift guidance.

#5 COIN – Coinbase Global, Inc. | OM Score -48.7 | Composite, 3/5 signature, Super Multiple -186.0, OM2 93.4, Trifecta Ratio 0.34. Coinbase is the largest US crypto exchange, earning trading, custody, staking and stablecoin revenue. The market treats it as a crypto proxy: a $51.3B market cap at 29.1x forward EV/EBITDA and 8.7x EV/Sales, with shares up 11% over 10 days and only ~4% below sell-side targets. Bear: MCR 92.6, BDR 94.6 and FRM 27.0, as revenue tracks volatile trading volumes. Bull: profitable, EQS 55.4, a 2.1% forward FCF yield and a deep regulatory moat. Biggest downside factor: earnings tied to crypto trading activity at a premium multiple (MCR 92.6). Risks to the short: (1) a bitcoin rally lifts the whole crypto cluster (7 names in this book); (2) US market-structure legislation; (3) beta 2.4.

#6 ASST – Strive, Inc. | OM Score -146.8 | Near Pass, 4/5 signature, Super Multiple -286.8, OM2 92.9, Trifecta Ratio 0.26. Strive is an asset manager turned bitcoin treasury company; buying Semler Scientific explains its Health Care sector label. The market values it on its bitcoin holdings: 280x forward EV/Sales, with shares up 13% over 10 days, 102% above their 200-day average and 36% above the OM target. Bear: ROIC -141% (worst in the book), EQS 29.5 and an operating business that is tiny next to the market cap. Bull: FRM 69.3, ~72% forward revenue growth and a growing bitcoin stack. Biggest downside factor: a valuation that depends on bitcoin and on issuing new stock (EV/Sales 280x). Risks to the short: (1) VSR 97.9, beta 3.4 and 23% short interest; (2) bitcoin rallies; (3) financing moves that boost bitcoin per share.

#7 TSAT – Telesat Corporation | OM Score -25.7 | Composite, 4/5 signature, Super Multiple -198.5, OM2 92.8, Trifecta Ratio 0.29. Telesat is a Canadian satellite operator with a geostationary fleet that is building Lightspeed, a low-earth-orbit broadband constellation. The market has bid it up as a LEO play while its legacy revenue shrinks. Bear: MCR 96.5, FRM 1.7, CAS 7.0, forward revenue expected to fall 26%, a -34% forward FCF yield and net debt ~4.7x market cap. Bull: government-backed Lightspeed financing, contracted backlog and scarce LEO assets. Biggest downside factor: a heavy balance sheet funding a multi-year build (CAS 7.0, net debt 4.7x market cap). Risks to the short: (1) beta 3.5 on a $743M market cap; (2) new Lightspeed customer or government contracts; (3) no sell-side target, so there is little valuation anchor and price moves run on headlines.

#8 NVTS – Navitas Semiconductor Corporation | OM Score -219.9 | Strict Pass, 3/5 signature, Super Multiple -349.2, OM2 92.2, Trifecta Ratio 0.15. Navitas designs gallium-nitride and silicon-carbide power chips and is pitching them for 800V AI data-center power. The market prices in that pivot: 39.5x forward EV/Sales, with forward revenue expected to fall 46%, and shares 66% above the OM target. Bear: MCR 99.0, FRM 1.2, ROIC -52% and an OM Score of -219.9, the weakest in the book. Bull: net cash ~19% of market cap, data-center design wins, and shares already 23% below their 200-day average. Biggest downside factor: a sales multiple disconnected from shrinking revenue (MCR 99.0). Risks to the short: (1) beta 4.6 and 15% short interest; (2) Nvidia-linked headlines spark sector rallies; (3) design-win announcements.

#9 FCEL – FuelCell Energy, Inc. | OM Score -113.9 | Near Pass, 4/5 signature, Super Multiple -177.0, OM2 91.7, Trifecta Ratio 0.03. FuelCell Energy builds fuel-cell power plants and is now pitching them as on-site power for data centers. The market has re-rated it on the AI-power theme: shares rose 9% over 10 days and sit 11% above their 200-day average. Bear: EQS 8.8, FRM 14.2, ROIC -18%, a -13% forward FCF yield and a long history of losses and dilution. Bull: net cash ~34% of market cap, data-center demand for off-grid power, and sell-side targets ~12% above the price. Biggest downside factor: persistent cash burn and weak earnings quality (EQS 8.8). Risks to the short: (1) 25% short interest and VSR 93.1; (2) a large data-center power contract could reset the story; (3) AI-power names move together on hyperscaler capex news.

#10 MSTR – Strategy Inc | OM Score -112.4 | Strict Pass, 5/5 signature, Super Multiple -352.4, OM2 90.2, Trifecta Ratio 0.07. Strategy (formerly MicroStrategy) is the largest corporate bitcoin holder, funding purchases with stock, convertibles and preferred shares. The market values it as leveraged bitcoin: a $59.1B market cap on 151x forward EV/Sales, with shares up 16% over 10 days. Bear: EQS 17.1, ROIC -57%, MCR 90.9, and the legacy software business is tiny next to the bitcoin balance sheet. Bull: bitcoin per share keeps growing, sell-side targets imply ~48% upside, and the preferred-stock program funds buying without selling bitcoin. Biggest downside factor: a valuation tied to bitcoin and to continued capital-market access (MCR 90.9). Risks to the short: (1) a bitcoin rally (beta 2.7); (2) index inclusion bringing passive buying; (3) shares can trade above the value of their bitcoin for long periods.

#11 AEHR – Aehr Test Systems, Inc. | OM Score -156.8 | Strict Pass, 2/5 signature, Super Multiple -342.3, OM2 90.0, Trifecta Ratio 0.44. Aehr makes wafer-level burn-in and test systems for silicon-carbide chips and, increasingly, AI processors. The market prices in an AI order ramp: 121.7x forward EV/EBITDA and 21.6x EV/Sales, with forward revenue expected to fall 15% and shares 13% above their 200-day average. Bear: MCR 98.1, FRM 12.0 and a lumpy, customer-concentrated order book. Bull: net cash, AI-processor burn-in qualifications, EQS 41.1 and sell-side targets ~37% above the price. Biggest downside factor: a peak multiple on falling revenue (MCR 98.1). Risks to the short: (1) beta 4.7 and 13% short interest; (2) a single large AI hyperscaler order can double the stock; (3) quarterly bookings surprises.

#12 QBTS – D-Wave Quantum Inc. | OM Score -95.3 | Near Pass, 3/5 signature, Super Multiple -235.3, OM2 90.0, Trifecta Ratio 0.31. D-Wave builds quantum-annealing computers and sells cloud access to them. The market treats it as a quantum-computing lottery ticket: a $6.4B market cap at 90x forward EV/Sales, with forward revenue expected to fall 44%. Shares sit 14% below their 200-day average, yet sell-side targets imply ~110% upside. Bear: MCR 99.5 (highest in the book), FRM 0.8 and ROIC -27%. Bull: a large cash balance funds years of R&D, and quantum is a top-tier retail theme. Biggest downside factor: a sales multiple far ahead of the business (MCR 99.5). Risks to the short: (1) beta 4.3 and 19% short interest; (2) big-tech or government quantum headlines spark sector-wide rallies; (3) equity raises add cash and extend the runway.

#13 KEEL – Keel Infrastructure Corp. | OM Score -95.9 | Near Pass, 5/5 signature, Super Multiple -217.4, OM2 89.9, Trifecta Ratio 0.00. Keel is the former Bitfarms, which rebranded in April 2026 and is moving from bitcoin mining to building data centers for AI and high-performance computing. The market is paying for the pivot ahead of results: 32.8x forward EV/Sales, with Q1 revenue down 22% and a $145M quarterly net loss. Bear: EQS 5.8, CAS 30.0, ROIC -41% and a -10% forward FCF yield. Bull: ~$533M of liquidity (May), a 2.2 GW power portfolio, an active buyback and sell-side targets ~61% above the price. Biggest downside factor: no tenant revenue yet on a pivot-priced multiple (EQS 5.8). Risks to the short: (1) one hyperscaler lease can re-rate the stock, as at peers; (2) 20% short interest and beta 2.9; (3) bitcoin rallies.

#14 CLSK – CleanSpark, Inc. | OM Score -71.3 | Near Pass, 5/5 signature, Super Multiple -239.4, OM2 89.7, Trifecta Ratio 0.16. CleanSpark is a US bitcoin miner that is adding AI and high-performance computing data-center capacity. The market prices it on bitcoin and AI optionality, with shares up 9% over 10 days. Bear: CAS 13.5, EQS 20.8, ROIC -38%, a -71% forward FCF yield (worst in the book) and net debt ~0.4x market cap. Bull: large owned power capacity, a bitcoin treasury and sell-side targets ~66% above the price. Biggest downside factor: heavy capex with little forward free cash flow (FCF/EV -0.71). Risks to the short: (1) 30% short interest (highest in the book) and beta 2.6, a classic squeeze setup; (2) an AI hosting lease announcement; (3) a bitcoin rally lifts miners together.

#15 HTFL – HeartFlow, Inc. | OM Score -149.0 | Near Pass, 3/5 signature, Super Multiple -225.0, OM2 89.1, Trifecta Ratio 0.29. HeartFlow uses AI to turn coronary CT scans into 3D models that measure blood flow and plaque without invasive procedures. The market has embraced the 2025 IPO: shares sit 60% above their 200-day average and trade 13% above sell-side targets. Bear: BDR 97.6, ROIC -61%, negative EBITDA and 15.2x forward EV/Sales. Bull: ~43% forward revenue growth, FRM 59.1, expanding Medicare reimbursement and a clear clinical advantage. Biggest downside factor: a stretched price after a big post-IPO run (BDR 97.6). Risks to the short: (1) growth that keeps beating estimates; (2) new reimbursement codes or guideline wins; (3) med-tech acquirers often buy high-growth diagnostics names.

#16 WGS – GeneDx Holdings Corp. | OM Score -97.7 | Near Pass, 4/5 signature, Super Multiple -256.0, OM2 89.1, Trifecta Ratio 0.22. GeneDx sells exome and genome sequencing tests for rare disease diagnosis, mainly in pediatric and NICU settings. Shares rose 17% over 10 days, sit 50% above their 200-day average and trade 12% above sell-side targets. Bear: BDR 98.4, 86.8x forward EV/EBITDA, ROIC -27% and EQS 25.5. Bull: ~25% forward revenue growth, FRM 53.7, positive EBITDA and leadership in rare-disease genomics. Biggest downside factor: a richly priced run-up (BDR 98.4, 86.8x EV/EBITDA). Risks to the short: (1) 20% short interest can fuel squeezes on beats; (2) expanding newborn-sequencing coverage; (3) low beta (0.77) means it may not fall with the market.

#17 RBRK – Rubrik, Inc. | OM Score -61.1 | Near Pass, 2/5 signature, Super Multiple -220.8, OM2 89.0, Trifecta Ratio 0.74. Rubrik sells data security and cyber-recovery software. Shares rose 20% over 10 days and sit 49% above their 200-day average, with no deal news found. Bear: 221x forward EV/EBITDA, 11.6x EV/Sales, ROIC -41% and BDR 91.5. Bull: FRM 89.7 (best in the short book), ~42% forward revenue growth, positive forward FCF and a strong Trifecta Ratio. Biggest downside factor: a peak multiple that needs flawless growth (221x EV/EBITDA). Risks to the short: (1) fundamentals are genuinely strong, which is why it only matches 2 of 5 top-1% short traits; (2) cybersecurity consolidation makes it a takeover candidate; (3) beta 2.1 in a momentum tape.

#18 MARA – MARA Holdings, Inc. | OM Score -107.1 | Near Pass, 5/5 signature, Super Multiple -169.9, OM2 88.9, Trifecta Ratio 0.00. MARA is the largest US-listed bitcoin miner and holds one of the biggest corporate bitcoin treasuries. The market trades it as leveraged bitcoin; shares rose 11% over 10 days. Bear: EQS 2.6, CAS 13.0, ROIC -59%, a -10% forward FCF yield and net debt ~0.4x market cap; flagged margin >70%, so its forward EBITDA likely includes bitcoin mark-to-market gains. Bull: a large bitcoin stack, low-cost power and sell-side targets ~39% above the price. Biggest downside factor: weak earnings quality behind the headline EBITDA (EQS 2.6). Risks to the short: (1) 28.5% short interest and beta 2.1; (2) a bitcoin rally; (3) an AI/HPC hosting deal like its peers have signed.

#19 RIOT – Riot Platforms, Inc. | OM Score -63.4 | Near Pass, 5/5 signature, Super Multiple -240.2, OM2 88.8, Trifecta Ratio 0.14. Riot mines bitcoin in Texas and is converting part of its power capacity into AI and high-performance computing data centers. The market prices that conversion in: 99.8x forward EV/EBITDA and 13.1x EV/Sales. Bear: EQS 11.4, CAS 37.5, ROIC -37% and a -15% forward FCF yield. Bull: FRM 51.0 with ~25% forward revenue growth, 1 GW+ of power capacity, a bitcoin treasury and sell-side targets ~36% above the price. Biggest downside factor: a data-center multiple with weak earnings quality (EQS 11.4). Risks to the short: (1) a signed hyperscaler or AI tenant lease; (2) a bitcoin rally; (3) beta 2.4 and 14% short interest.

#20 CIFR – Cipher Digital Inc. | OM Score -79.7 | Near Pass, 5/5 signature, Super Multiple -279.0, OM2 88.4, Trifecta Ratio 0.00. Cipher Digital (formerly Cipher Mining) is turning its Texas bitcoin-mining sites into AI and high-performance computing data centers under long-term leases. The market has rewarded the leases: 21.8x forward EV/Sales, with shares up 9% over 10 days. Bear: EQS 4.6, CAS 15.7, ROIC -32%, a -25% forward FCF yield and net debt ~0.6x market cap from the buildout. Bull: contracted hyperscaler-linked lease revenue, ~20% forward revenue growth and sell-side targets ~74% above the price. Biggest downside factor: debt-funded construction ahead of lease cash flows (CAS 15.7). Risks to the short: (1) new lease signings; (2) 17% short interest and beta 2.2; (3) AI capex headlines lift the whole data-center group.

#21 SWKS – Skyworks Solutions, Inc. | OM Score -61.4 | Near Pass, 2/5 signature, Super Multiple -117.6, OM2 88.0, Trifecta Ratio 0.38. Skyworks makes RF chips for smartphones and wireless devices and closed its Qorvo merger on 10-5. Shares rose 16% over 10 days, sit 35% above their 200-day average and trade 27% above sell-side targets. Bear: BDR 98.1, ROIC -2%, heavy reliance on Apple and integration risk. Bull: EQS 56.8, CAS 55.7, a 6.2% forward FCF yield and $500M+ targeted cost savings. Biggest downside factor: a price stretched past targets (BDR 98.1). Risks to the short: (1) the model’s $13.4B market cap and estimates may not yet reflect the Qorvo share issuance, so scores could be distorted; (2) synergy upgrades after the merger; (3) a stronger smartphone cycle.

#22 IBTA – Ibotta, Inc. | OM Score -36.2 | Composite, 2/5 signature, Super Multiple -105.9 (mildest in the book), OM2 87.8, Trifecta Ratio 0.48. Ibotta runs a performance-marketing network that pays consumers cash-back rewards on packaged-goods purchases through its app and retail partners. The market has bid it up: BDR 94.5, with shares 9% above sell-side targets. Bear: forward revenue expected to fall ~7%, FRM 32.0, ROIC -3% and VSR 90.7. Bull: a 5.2% forward FCF yield, net cash ~13% of market cap, CAS 58.8 and buybacks. Biggest downside factor: shrinking revenue at a stretched price (BDR 94.5). Risks to the short: (1) the weakest signals in the book (Composite, Score -36.2); (2) buybacks and positive FCF support the stock; (3) beta 2.1 and 14% short interest.

#23 HUT – Hut 8 Corp. | OM Score -131.1 | Strict Pass, 5/5 signature, Super Multiple -371.1 (most negative in the book), OM2 87.8, Trifecta Ratio 0.22. Hut 8 runs power and digital infrastructure, owns a majority of American Bitcoin, and is developing AI data-center campuses. The market prices the AI pipeline: 229x forward EV/EBITDA and 61.7x EV/Sales. Bear: EQS 7.3, CAS 18.6, ROIC -11%, a -17% forward FCF yield and net debt ~0.6x market cap. Bull: ~130% forward revenue growth, FRM 61.1, and sell-side targets ~64% above the price. Biggest downside factor: a valuation far ahead of cash generation (SMP -371.1). Risks to the short: (1) beta 3.0 and 12% short interest; (2) new AI tenant leases at its campuses; (3) bitcoin rallies through its American Bitcoin stake.

#24 VOYG – Voyager Technologies, Inc. | OM Score -77.4 | Near Pass, 5/5 signature, Super Multiple -133.6, OM2 87.8, Trifecta Ratio 0.32. Voyager builds defense and space technology, including missile components and the planned Starlab commercial space station. The market treats it as a space and defense theme stock after its 2025 IPO. Bear: EQS 9.5, ROIC -19%, a -12% forward FCF yield and only ~11% forward revenue growth. Bull: a growing defense backlog, NASA commercial-station funding and sell-side targets ~30% above the price. Biggest downside factor: losses and cash burn behind a theme valuation (EQS 9.5). Risks to the short: (1) beta 4.8 (highest in the book) and VSR 96.6; (2) defense budget or Golden Dome-style contract headlines; (3) Starlab milestones or NASA awards.

#25 BBNX – Beta Bionics, Inc. | OM Score -151.7 | Near Pass, 2/5 signature, Super Multiple -210.8, OM2 87.8, Trifecta Ratio 0.28. Beta Bionics sells the iLet bionic pancreas, an automated insulin-delivery system, and is developing the Mint patch pump. The model shows +26% over 10 days and a $21.89 price, but the stock opened at $16.75 on 10-30 after Q3 earnings, so the file price looks stale and part of the move has already reversed. Bear: BDR 97.5, ROIC -26%, negative EBITDA and a securities class action (lead-plaintiff deadline 11-3). Bull: ~53% forward revenue growth, FRM 58.8 and net cash ~15% of market cap. Biggest downside factor: a stretched price with legal overhang (BDR 97.5). Risks to the short: (1) the post-earnings drop already captured much of the downside; (2) Mint launch progress; (3) med-tech acquirer interest.

Thank you for reading this week’s issue of The Oddsmaker. If you would like to view more content like this, or access the Oddsmaker Universe and find every stock tracked by the Oddsmaker all in one place, visit our website:

See you next week.

- The Oddsmaker Team

Disclosure & Disclaimer

The Oddsmaker is a financial media and research publication provided for informational and educational purposes only. Nothing contained herein constitutes investment advice, a recommendation to buy or sell any security, or legal, tax, or accounting advice. The Oddsmaker, its affiliates, employees, contributors, related parties, and associated accounts may hold long, short, or other positions in securities discussed and may buy or sell such securities without notice. Any scores, rankings, ratings, probabilities, expected returns, forecasts, analytics, models, simulations, or backtested results are hypothetical analytical opinions based on assumptions and methodologies that may prove incorrect. They are not guarantees of future performance or outcomes. Information is obtained from sources believed to be reliable; however, The Oddsmaker makes no representation or warranty as to its accuracy, completeness, or timeliness. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Readers are solely responsible for conducting their own due diligence and consulting qualified financial, legal, tax, and accounting professionals before making investment decisions.

© The Oddsmaker. All rights reserved.